SEC Tracker
Get the app

Annovis Bio ANVS

Annovis Bio reschedules meeting to Nov 3

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. Rescheduled from Oct 14 to Nov 3
  2. Amended Proposal 1 to only increase common stock
  3. Brokers now have voting discretion for Proposal 1
  4. Record date remains Sept 4

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Annovis Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Abvc Biopharma ABVC public float $37M, Jun 30, 2025
  2. Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
  3. Grace Therapeutics GRCE public float $35M, Sep 30, 2025
  4. BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
  5. Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025